Designing the next generation of cryoprotectants – From proteins to small molecules
Peptide Science · 2019-01 · 111 (1)
DOI: 10.1002/pep2.24086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Peptide Science, online erschienen am 12.09.2018. Verfasst von Anna Ampaw und 3 weiteren Autor:innen. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 126 Literaturangaben.
Abstract (Originalsprache)
During the past decade, there have been many exciting advances in the fields of cellular therapies, regenerative medicine, and tissue engineering. However, current cryopreservation strategies and protocols result in inferior product after thawing. Thus, novel cryoprotectants and protocols capable of meeting the high‐quality product(s) necessary for these therapies are urgently required. The search for new and improved cryoprotectants has been ongoing but novel small molecule ice recrystallization inhibitors, originally developed from naturally occurring antifreeze proteins, have demonstrated tremendous promise and will play a significant role in fully translating cellular and regenerative therapies into the clinical environment.
Zitieren
APA
Ampaw, A., Charlton, T. A., Briard, J. G., & Ben, R. N. (2019). Designing the next generation of cryoprotectants – From proteins to small molecules. Peptide Science, 111(1). https://doi.org/10.1002/pep2.24086
Vancouver
Ampaw A, Charlton TA, Briard JG, Ben RN. Designing the next generation of cryoprotectants – From proteins to small molecules. Peptide Science. 2019;111(1). doi:10.1002/pep2.24086
BibTeX
@article{Ampaw2019,
author = {Ampaw, Anna and Charlton, Thomas A. and Briard, Jennie G. and Ben, Robert N.},
title = {Designing the next generation of cryoprotectants – From proteins to small molecules},
journal = {Peptide Science},
year = {2019},
volume = {111},
number = {1},
doi = {10.1002/pep2.24086}
}
EUVIMED